Evidence map›Paper›PMID 35596201›Full record

ArticleBMC complementary medicine and therapies2022

Chemical composition, antibiofilm, cytotoxic, and anti-acetylcholinesterase activities of Myrtus communis L. leaves essential oil.

Lucia Caputo, Francesca Capozzolo, Giuseppe Amato, Vincenzo De Feo, Florinda Fratianni, Giovanni Vivenzio, Filomena Nazzaro

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Optimization of TunisianMetabolites · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Antibacterial activity ofFrontiers in plant science · 2025
    Article
  9. Antimycobacterial and Anticancer Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  10. Natural compounds in the fight againstFrontiers in pharmacology · 2024
    Review
  11. Kaempferol restores the susceptibility of ESBLsFrontiers in microbiology · 2024
    Article
  12. Article
  13. Article
  14. Antimicrobial Effects and Antioxidant Activity ofFoods (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. The Leaf Essential Oil ofPlants (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lucia CaputoDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, 132, 84084, Fisciano, Salerno, Italy.
Francesca CapozzoloDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, 132, 84084, Fisciano, Salerno, Italy.
Giuseppe AmatoDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, 132, 84084, Fisciano, Salerno, Italy.
Vincenzo De FeoDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, 132, 84084, Fisciano, Salerno, Italy. defeo@unisa.it.
Florinda FratianniInstitute of Food Science, CNR-ISA, via Roma 64, 83100, Avellino, Italy.
Giovanni VivenzioDepartment of Pharmacy, University of Salerno, via Giovanni Paolo II, 132, 84084, Fisciano, Salerno, Italy.
Filomena NazzaroInstitute of Food Science, CNR-ISA, via Roma 64, 83100, Avellino, Italy.
University of Salerno · ITInstitute of Food Science · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe potential of essential oils (EOs) and of their principal constituents for eradication of biofilm and at the same time the research of new potential acetylcholinesterase inhibitors is gaining increasing interest in last years. The aims of this study were to determine the chemical composition and to evaluate the antibacterial, cytotoxic, and anti-acetylcholinesterase properties of Myrtus communis leaves essential oil and its main constituents.

methodsEssential oil was obtained by hydrodistillation of M. communis L. leaves and was analyzed by GC and GC-MS. The antimicrobial activity was carried out against both gram-negative and gram-positive bacteria. The microdilution method was used to estimate the minimum inhibitory concentrations (MICs). Then, the capacity of essential oil and its main constituent to inhibit biofilm growth, with the method of O'Toole and Kolterand, and the metabolic activity of biofilm cells through the MTT colorimetric method were evaluated at different times. Moreover, was studied the potential cytotoxic activity against SH-SY5Y cell line with MTT assay and the anti-acetylcholinesterase activity using Ellman's assay.

resultsMyrtenyl-acetate, 1,8 cineole, α-pinene, and linalool were the main components in the EO. The myrtle EO, at the minimum tested dose (0.4 mg/ml), inhibited S. aureus biofilm by 42.1% and was capable of inhibiting the biofilm cell metabolism in all tested strains, except Staphylococcus aureus. Moreover, the EO showed good cytotoxic and anti-acetylcholinesterase activities IC

conclusionsThe results suggest that myrtle EO and its main constituents could be used as possible products that could act against the resistant pathogenic species E. coli, P. aeruginosa, L. monocytogenes and S. aureus, on the other hand, as possible coadjutants in the treatment of neurological diseases.

Indexed as

Cholinesterase InhibitorsMyrtusOils, VolatileAcetylcholinesteraseBiofilmsCell Line, TumorEscherichia coliHumansPlant LeavesStaphylococcus aureusAcetylcholinesteraseCholinesterase InhibitorsOils, VolatileAnti-acetylcholinesterase activityAntibacterial activityBiofilmBiofilm metabolismCytotoxic activityEssential oilMyrtus communisSH-SY5Y cells

Identifiers

PMID35596201
PMCPMC9123742
OpenAlexW4281256272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.